Navigation Links
NimbleGen microarrays speed genetic findings

Madison, Wis. - Research into the genetic underpinnings of mental retardation has been expidited thanks in part to technology from a local biotechnology company.

Researchers at the University of Washington and the Howard Hughes Medical Institute discovered new genetic causes of mental retardation, documente......

Full article >>> d in one in five people of European descent and seems to occur preferentially among children of individuals who carry the inversion.

The research was based on the hypothesis that the genome contains "hotspots" that are prone to instability and flanked on each side by large, repetitive regions of DNA, termed "segmental duplications." It is because of the repetitive nature of these regions ......

Full article >>>
'"/>

Source:wistechnology.com By WTN News 08/11/06


Related biology technology :

1. NimbleGen researcher to lead $415K DNA project
2. NimbleGen to discontinue IPO after Roches $272.5 million acquisition
3. IPO-bound NimbleGen traveling in fast company
4. Madison biotech NimbleGen files for IPO; one of states best-funded firms
5. Genomics researcher Hood joins NimbleGen board
6. NimbleGen partners with UK biotech firm
7. NimbleGen extends research market reach
8. NimbleGen names CFO with capital-raising past
9. NimbleGen partners with leading researchers
10. NimbleGen closes $8.2m venture round, bringing total to $50m
11. NimbleGen Systems CGS technique helps identify stomach bacteria
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/27/2017)... 27, 2017 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed") (CSE: IN; ... Friday, February 24, 2017 a total of 10,672,750 common share ... per common share. Proceeds from the exercise of these warrants ... Treasury.   ... "We are grateful for this expression of confidence by our ...
(Date:2/27/2017)... and HAMILTON, Bermuda ... (NASDAQ: ADXS ) and ... companies focused on developing cancer immunotherapies, today announced ... develop a novel cancer immunotherapy agent using Advaxis, ... SELLAS, patented WT1 targeted heteroclitic peptide antigen mixture ...
(Date:2/27/2017)... ... ... The Catalyst Midwest premix manufacturing facility has been certified as organic, ... label organic services. , The first organic product is Organic 18 Percent Layer Feed, ... Marketing, which owns the facility. , Catalyst already has received the Safe Feed/Safe ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... can be safely completed in an ambulatory surgery center (ASC) with satisfactory clinical ... and previous two-year TDR studies. , Jake Lubinski, president of AxioMed, commented ...
Breaking Biology Technology:
(Date:2/13/2017)... , Feb. 13, 2017  RSA Conference -- ... platform that is designed to enhance fraud detection ... release in the RSA Fraud & Risk Intelligence ... organizations to leverage additional insights from internal and ... to better protect their customers from targeted cybercrime ...
(Date:2/8/2017)... Inc. (NASDAQ: AWRE ), a leading supplier of ... quarter and year ended December 31, 2016. ... compared to $6.9 million in the same quarter last year. ... million compared to $2.6 million in the fourth quarter of ... $0.5 million, or $0.02 per diluted share, which compares to ...
(Date:2/7/2017)... Ind. , Feb. 7, 2017 Zimmer ... leader in musculoskeletal healthcare, will present at the LEERINK ... New York Palace Hotel on Wednesday, February 15, 2017 ... live webcast of the presentation can be accessed at ... replay following the conference via Zimmer Biomet,s Investor Relations ...
Breaking Biology News(10 mins):